Last reviewed · How we verify
NCT06151483
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension
NA trial testing Alpha-Agonist in Outcome in 1,184 participants. Completed in 19 August 2024.
19 August 2024
Quick facts
| Lead sponsor | General Hospital of Ningxia Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,184 |
| Start date | 1 December 2023 |
| Primary completion | 19 August 2024 |
| Estimated completion | 19 August 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Alpha-Agonist — full drug profile →
- α-adrenergic receptor agonist — full drug profile →
Conditions studied
- Outcome — all drugs for Outcome →
Sponsor
General Hospital of Ningxia Medical University
Who can join
Adults 18 to 45, female only, with Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to investigate the impact of varying maternal blood pressure maintenance targets on neonatal outcomes following cesarean section.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06151483
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alpha-Agonist
Trials testing the same drug.
- NCT06151470 — 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients · NA · unknown
- NCT06151522 — 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment · NA · unknown
- NCT06151457 — 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients · NA · unknown
- NCT06151509 — 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment · NA · unknown
- NCT06151496 — Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics · NA · unknown
Other recruiting trials for Outcome
Currently open trials in the same condition.
- NCT07013175 — Wise Choices in the Intensive Care Unit · NA · recruiting
- NCT06011187 — Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery · NA · recruiting
- NCT06165081 — The Association Between Post-resuscitation Time Series Management in the Emergency Department and Short-term Outcomes fo · recruiting
- NCT06836687 — Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure · recruiting
- NCT03893136 — The Registry Study of Takayasu Arteritis in East China · recruiting
Other General Hospital of Ningxia Medical University trials
Trials by the same sponsor.
- NCT07496086 — External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative · NA · recruiting
- NCT07396545 — External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastr · NA · recruiting
- NCT07366853 — Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach · NA · not yet recruiting
- NCT07239531 — The Application of Intermittent Training in Clinical Skills Simulation Training · NA · not yet recruiting
- NCT07248683 — Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line G · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06151483 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Hospital of Ningxia Medical University
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06151483.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing